The effect of age on the distribution and elimination of sufentanil was studied in seven elderly and seven younger (41 +--15 
procedures neuro-chirurgicales. Apr~s un bolus intraveinettr unique de sufentanil de 2 tzg. kg -t , des ~chantillons art~riels multiples ont Et~ obtenus ~ des intervalles rt~guliers et des concentrations plasmatiques de sufentanU ont dtd mesurdes par radio-immuno-essai. Les variables pharmacocinEtiques ont ErE calculEes. Le volume initial de distribution t~tait significativement plus petit chez les patients plus 6gEs (3 I0 +-109 ml. kg-t moyenne +--SD). Les demi-vies d'Elimination, les clairances plasmatiques, les volumes totatLr de distribution dtaient similaires pour les patients Bgds et les sujets plus jeunes. Six des sept patients dgEs ont reqais I' administration de naloxone ti latin de la chirurgie afin d'acqudrir une frEquence de ventilation ad~quate (> 8 respirations" mitt -I ) alors qu'un seul patient plus jeune a requis un antagonisme de sa depression respiratoire. Les attteurs croient que les differences reli~es ti I' dge dans l'effet du sufentanil ne peuvent dtre attribuEes au, r differences du voh~me de distribution initia I. On conclut que les alterations de la pharmacodynamique apparaissent phts importante clans la prolongation des effets des opiac~s observes chez les gens dgEs.
It is well established that physiological changes accompanying advanced age can alter drug distribution and elimination (pharmacokinetics). Changes which may affect drug distribution in the elderly, especially in the case of opioids, are a decrease in total body water, 1'2 decreased total cell mass, 3 a relative decrease in lean body mass, 3,4 increased body fat, 3'4 and decreased serum albumin 5 with decreased protein binding of drugs. In addition, drug elimination in the elderly may be altered by decreased cardiac output, 6 reduced hepatic blood flow with a slowed delivery of drug to the liver, 7'8 and a possible decrease in active metabolism of drugs in the liver. 9 Furthermore, studies have clearly demonstrated that the elderly are more sensitive to the analgesic and respiratory depressant effects of opioids than younger patients. ~o-~2
With this background in mind, this study was designed to determine the pharrnacokinetics of sufentanil in elderly surgical patients.
Methods
Following Institutional Review Board approval, informed consent was obtained from all patients. Seven elderly (age CAN J ANAESTH 1990 / 37:8 / pp852-6 over 70 yr) and seven younger (less than 60 yr) patients undergoing elective neurosurgery were studied. In the elderly group, the operations included three carotid endarterectomies, three lumbar laminectomies and one cervical laminectomy. In the younger group, there were five lumbar laminectomies, one cervical laminectomy and one transphenoidal adenomectomy. All patients had normal liver function and no evidence of cardiac failure. Premedication in most cases consisted of intramuscular secobarbital (50-120 mg) and atropine (0.3-0.5 mg), though three of the elderly received atropine alone. Anaesthesia was induced with thiopentone 3-6 rag. kg-] IV and tracheal intubation was facilitated with succinylcholine (I .0-!.5 rag' kg -t IV) following precurarization with vecuronium I mg IV. Anaesthesia was maintained with N20, O2 (60, 40 per cent), isoflurane 0.25-0.5 per cent (inspired concentration) and a continuous infusion of vecuronium to obtain muscle relaxation. Body temperature was continuously monitored via an oesophageal probe and varied no more than 1 ~ C throughout the entire procedure. A steady state end-tidal carbon dioxide tension (ETCO2) was established in each patient which ranged between 31-37 mmHg, after which an arterial blood sample was obtained to determine arterial carbon dioxide tension (PCO-,). The steady state ETCO2 was maintained throughout the procedure. At this time, sufentanil (2 In, g" kg-i) was injected intravenously as a bolus. Heparinized arterial blood samples were obtained at 1,3, 5, 10, 15, 20, 30, 45,60 min and at half-hour intervals thereafter to four hr. Plasma was separated and frozen until assayed by radioimmunoassay (sensitivity 0. I ng. ml-'; coefficient of variation 8.5 per cent), t3 At least 30 min before the termination of surgery, isotlurane was discontinued and anaesthesia then maintained with N20 and vecuronium. At the end of anaesthesia, following reversal of the muscle relaxant, it was determined if the patient's respiration was so depressed as to require a narcotic antagonist. The criterion for respiratory depression was eight breaths, rain -t or less. If required, naloxone in 50 p,g increments was given intravenously. The time from injection of sufentanil until extubation of each patient was noted.
Both bi-and tri-exponential equations were fitted to the plasma concentration-time curves from each patient, using weighted, nonlinear least squares regression analysis (') (BMDP). 14 A weighting function Xs of Vg was used. The best fit for the data was then determined by the method of Boxenbaum. ts Pharmacokinedc variables were calculated by using a standard method for bolus IV injection of a drug. ~6 Total volume of distribution was determined by the area method. Comparisons of the pharmacokinetic variables between elderly and young patients were made by applying Student's t test for unpaired data (twotailed). The groups' characteristics and intraoperative conditions were similarly compared. The male:female ratio was compared using chi-square. The threshold for statistical significance was P < 0.05.
Results
The demographic characteristics of the groups, intaoperative conditions and selected laboratory data are presented in Table i . When the two study groups were compared with regard to age, weight, sex, duration of anaesthesia, arterial CO2 tension, body temperature, total protein and serum albumin, only in age were the groups significantly different. No patient in either group required a blood transfusion. The plasma concentration-time course curves for each group are displayed in the Figure. Plasma decrement curves for all patients were best Tables I1 and llI . The initial volume of distribution was significantly smaller in the elderly than the younger patients. This reflects an initially higher plasma concentration of sufentanil in the elderly patients studied. There were no significant differences in any of the other pharmacokinetic variables when the elderly were compared with the younger controls. At the termination of surgery six of seven elderly patients and one of seven younger patients required administration of naloxone to achieve a rate of ventilation greater than eight breaths per minute.
Discussion
Clinical studies have clearly established that the elderly are more sensitive to the analgesic and respiratory depressant effects of narcotics than younger patients. ~o-~z Are these observations in the elderly related to the changes in the distribution and elimination (pharmacokinetics) of narcotics or changes in their action within the central nervous system? Fentanyl and its analogues, sufentanil and alfentanil, exhibit many characteristics that could be influenced by the physiological changes that accompany the aging process. These drugs exhibit a high clearance with a high hepatic extraction ratio and are thus sensitive to changes in splanchnic blood flow. Sufentanil, alfentanil and fentanyl depend almost exclusively on phase 1 drug metabolism (N-demethylation, hydroxylation) in the liver. This process decreases with increasing age. 9 Plasma protein binding is 92 per cent with sufentanil and alfentanil and slightly lower with fentanyl (84 per cent bound). Thus a decrease in serum albumin would make more free drug available for binding on the opiate receptors. These narcotics are lipophylic drugs with sufentanil having the greatest lipid solubility (octanol number, 1754). The elderly with increased total body fat might sequester more narcotic in their fatty tissues. All of these factors suggest that the pharmacokinetics of these narcotics would be markedly altered in the elderly.
The pharmacokinetics of fentanyl were first studied in elderly patients by Bentley et al. 17 They reported that elderly patients (over age 60 yr), when compared with younger patients, had a reduced plasma clearance (4.0 --+ 0.6 vs 15.4 +--1.6 ml.min -I kg -I) and a prolonged t 89 (945 -4--64 vs 265 +--22 rain). There was no significant age-related difference in volumes of distribution. In contrast, Scott and Stanski could not demonstrate any significant pharmacokinelic changes between the elderly and younger patients given fentanyl. 18 Most recently, Singleton et al. ~9 found the clearance of fentanyl to be similar in elderly and younger patients, while the steadystate volume of distribution was significantly smaller in the elderly. The concentration of fentanyl was greater in the elderly at one and four minutes after injection, but was not significantly different during the remainder of the study. These authors felt that any age-related differences in response to fentanyl were most likely related to a higher initial fentanyl concentration in the elderly.
Conflicting pharmacokinetic data have also been reported for alfentanil. Helmers et al. 2~ repotled that when elderly patients (over age 65 years) were compared with younger controls the elderly exhibited decreased plasma clearance (4.37 ---2.6 vs 6.47 --+ 2.1 ml.min -t kg -~) and a prolonged t 89 (137 ---33 vs 83 ---23 rain). They found no difference in the volumes of distribution between the two groups. Again, Scott and Stanski could find no age-related pharmacokinetic changes for alfentanil. ~8
Our pharmacokinetic data are similar to those previously reported for sufentanil in anaesthetized patients. Bovill et al. administered sufentanil 5 ~g. kg -I to ten surgical patients and derived an elimination half-life of 167 min, total volume of distribution of 2860 ml. kg-i and plasma clearance of 12.66 ml .kg -~ 9 min-I. 2~ The control group of Sear et al., after receiving 2.5 la,g. kg-~ of sufentanil, had an elimination half-life of 185 min, volume of distribution of about 2966 ml.kg -~ and clearance of about 18.1 ml'kg-I'min-~. 22 These values are all in close agreement with control values previously reported by our group (elimination half-life 143 min, volume of distribution 3518 ml'kg -I, clearance 17.3 ml'kg -I 'min -I) for neurosurgical patients receiving 4 Ixg" kg-~ of sufentanil. 23 The control values for kinetic variables in the present study fall well within the range established by previous investigators. This lends validity to the pharmacokinetic values we report in our elderly group. In addition, in this study there is no significant difference in serum albumin between the two groups. Thus, protein binding is not a factor in this study.
The age-related differences in the action of sufentanil reported in this study do not appear to be related to any difference in the major pharmacokinetic variables (i.e., plasma clearance, total volume of distribution, elimination half-life). The initial volume of distribution of sufentanil in the elderly, however, is significantly de- creased when compared with the younger controls. The decrease in the initial volume of distribution reflects a higher initial plasma concentration of the drug. It is attractive to postulate that this initial increase in sufentanil concentration may be responsible for age-related responses to the narcotic. In fact, Singleton t9 has advanced this concept for fentanyl. The work of Scott and Stanski,~s however, appears to refute this concept. In a combined pharmacokinetic and pharmacodynamic study, Scott and Stanski infused either fentanyl or alfentanil in elderly and young. The electroencephalogram (EEG) was employed to measure narcotic action while blood samples were analyzed for each narcotic to quantitate drug distribution and elimination. In examining their data, it appears that the peak electroencephalographic response either coincides with or closely follows the peak serum narcotic concentrations. Further, once the narcotic infusions were stopped, serum concentrations of the drugs declined and concurrently the EEG's reverted towards the pre-narcotic control values. Since the action of the narcotics appears to follow serum concentration closely it does not appear that a brief initial increase in serum narcotic concentration would in and of itself account for the prolonged action of a narcotic. The weight of most recent evidence now suggests that any prolongation of action of sufentanil and its analogues in elderly patients is unlikely to be related to changes in the classical pharmacokinetic variables of these drugs. Alteration in pharmacodynamic behavior appears to be of greater importance in the prolonged opioid effect seen in the elderly.
